Buy Magnetic Beads
directly here:
Online Shop



Read our
latest news
here



Need Support? We will assist you with our support team: Contact us 


Press


NEW: Dynabeads® Replacement Guide PDF Print

NEW: Dynabead® replacement guide for MagSi Beads


MagSi bead products are available from MagnaMedics Diagnostics BV since 2004. The MagSi bead range covers most of the application areas in genomics and proteomics. The products are proven in a lot of low, medium and high throughput protocols. The MagSi particles are high quality magnetic beads with unique surface and physical properties.

Invitrogen anounces the discontinuation of the Dynabead® product line for proteomics applications (www.invitrogen.com).

MagnaMedics delivers with its MagSi products, a perfect solution for replacing the competitive Dynabeads® – without major changes in protocols or  handling. MagSi products have a proven track record for manual use and many robotic platforms (Beckmann® , Tecan®, IDS®, Xyril®, Stratek®, Hamilton®, Roche® and others). MagnaMedics application specialists will assist you when needed, to make the transfer to MagSi products possible.


Please look HERE for more information and the replacement Table.

Download HERE the Dynabeads Replacement Guide (pdf).


 
Summer Promotion 50% discount PDF Print

MagnaMedics Diagnostics BV has developed a portfolio of magnetic nanoparticles specifically suited for use in proteomics research & studies. Details on those products can be found here. MagSi- proteomics and MagSi-WCX particles are specifically suited for:

  • - desalting after (tryptic) digest

  • - biomarker ID and validation from various human sample sources

  • - protein target capture, isolation and enrichment

  • - automated Peptide Mass Fingerprinting

  • - proteomics automation and liquid handling applications


The following beads can now be ordered with a 50% discount:

Art. Nr.
Product
Conc.
Size
Volume
Price
(-50%)*
MD01014
MagSi-proteomics C4
10 mg/ml
1.2 µm2 ml
115
MD01015
MagSi-proteomics C8
10 mg/ml1.2 µm2 ml115
MD01009
MagSi-proteomics C18
10 mg/ml1.2 µm2 ml115
MD01023
MagSi-WCX
20 mg/ml1.2 µm2 ml115

* Prices are excluding VAT and shipping costs


This offer is valid until July 15th 2010!


If you have any questions, please feel free to contact us at:
Tel: +31 46 820 0206
Fax: +31 46 410 6825



 
MagnaMedics upgraded various MagSi catalogue products with a new high magnetic content bead type to increase the performance up to 6 times. PDF Print

MagnaMedics Diagnostics B.V. has developed a high magnetic content bead type with a size of 1.2 μm and 1.0 μm. The use of a new developed novel ferro fluid (Mag-Ferro) with an magnetisation of up to 40 emu/g allows MagnaMedics to upgrade the catalogue products.Raising the magnetic content from formally 30 – 40% to 40% - 55% enhances the time to magnet significantly.

Click here to read the full Product Update.

 
Compatibility of MagSi-DNA beads with Roche nucleotide extraction kit buffers PDF Print

MagnaMedics Diagnostics B.V. (MMD) has tested its MagSi-DNA silica beads in a compatibility study using the buffers of Roche LC Nucleic Acid Isolation kits. Background of this study is the fact that clients have adopted diagnostic protocols which resulted in left over Roche buffers from these kits that. This created the opportunity for MagnaMedics Diagnostics and its partners (here: Academic Hospital Maastricht (AZM)) to investigate efficient integration of MagSi-DNA particles with these (left over) buffers.

Read more...
 
MagnaMedics at 3rd European Conference for Clinical Nanomedicine, Basel. PDF Print


The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. The recognition of the large future impact of nanoscience on medicine and the observed rapid advance of medical applications of nanoscience have been the main reasons for the creation of the Foundation. This year CLINAM organizes its 3rd annual conference and a series of world-experts will be present to speak on various topics.

Paul Borm, CSO of Magnamedics will speak at this conference about clinical use and imaging using magnetic nanoparticles. In addition as an international expert in the toxicology field he will chair the session about nanomaterial toxicology. The conference will be held on May 10-12, 2010 in Basel, Switzerland.

For more information and registration, please visit the website www.clinam.org.

 
« StartPrev123NextEnd »

Page 1 of 3